NorthStar Medical Radioisotopes Signs Master Supply Agreement with Cellectar Biosciences for Therapeutic Radioisotope Actinium-225
NorthStar Medical Radioisotopes Signs Master Supply Agreement with Cellectar Biosciences for Therapeutic Radioisotope Actinium-225
11/21/24, 1:07 PM
Location
beloitIndustry
medical device
medical
biotechnology
health care
Type
agreement
NorthStar Medical Radioisotopes, LLC has executed a strategic Master Supply Agreement with Cellectar Biosciences, Inc. under which Cellectar will acquire and integrate NorthStar's n.c.a. Ac-225 into Cellectar's proprietary Phospholipid Ethers (PLE) delivery platform to expand the platform's capability to produce a diverse range of radiotherapeutic molecules.
Company Info
Location
beloit, wisconsin, united states
Additional Info
NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, is a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases.